This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock ...
This clinical-stage biotech focused on long-acting antibody therapies reported a notable insider sale amid ongoing pipeline ...
2-Year U.S. Treasury Note Continuous Contract $104.250 0.012 0.01% 5-Year U.S. Treasury Note Continuous Contract $109.070 0.023 0.02% 10-Year U.S. Treasury Note Continuous Contract $112.234 0.016 0.01 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback